Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Toutongning is a Traditional Chinese Medicine (TCM) formulation, typically administered as a capsule, used primarily for the treatment of migraine, tension-type headaches, and trigeminal neuralgia. Developed and manufactured by companies such as Shaanxi Buchang Pharmaceuticals, it is composed of several herbal and animal-derived ingredients, including *Arisaema cum Bile*, *Gastrodia elata*, *Ligusticum chuanxiong*, and *Angelica dahurica*. The formulation is designed to "dispel wind, resolve phlegm, and activate blood circulation" according to TCM principles. Clinical studies, including those conducted by the Chinese PLA General Hospital, have evaluated its efficacy in reducing the frequency and severity of migraine attacks, potentially through mechanisms involving the regulation of neurotransmitters and anti-inflammatory pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Toutongning.